TWO SIGMA INVESTMENTS, LP
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1179392
NEW YORK, NY
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,470,947
+$1,723,371 QoQ
Shares Held
1,579,840
+86.9% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 97.91118087907637.ToString("F0")%
Shared 0.ToString("F0")%
None 2.0888191209236378.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,509,413,147 across 314 Biotechnology names. MRVI ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,470,947 | 1,579,840 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,747,576 | 845,408 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,364,351 | 1,172,248 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,211,954 | 1,332,761 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,170,180 | 1,434,471 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $596,333 | 109,419 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,271,472 | 273,342 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,820,072 | 254,200 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,284,037 | 494,122 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $962,168 | 146,896 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,452,690 | 545,269 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,368,584 | 2,362,718 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,248,948 | 1,802,209 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,273,042 | 1,556,467 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,742,645 | 538,294 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,678,747 | 622,272 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,323,123 | 632,921 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,048,272 | 406,880 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,458,068 | 29,708 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $18,322,641 | 439,076 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,919,421 | 222,206 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,083,953 | 288,198 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||